Bildkälla: Stockfoto

Medivir: Further Improvements with Fostrox - Redeye

Redeye comments on the slightly improved data, which are becoming mature, from the latest readout of the trial of fostrox in combination with Lenvima in liver cancer.

Redeye comments on the slightly improved data, which are becoming mature, from the latest readout of the trial of fostrox in combination with Lenvima in liver cancer.
Börsvärldens nyhetsbrev
ANNONSER